Shandong Institute of Endocrine and Metabolic Diseases, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.
Department of Geriatrics, Department of Geriatric Endocrinology, ShanDong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Diabetes Res Clin Pract. 2020 Oct;168:108249. doi: 10.1016/j.diabres.2020.108249. Epub 2020 Jun 10.
Cardiovascular disease is a major cause of death and disability worldwide. Recently, increasing evidence has demonstrated that various lncRNAs play critical roles in the pathogenesis of cardiovascular diseases, including myocardial ischemia and reperfusion (I/R) injury. LncRNAs are transcripts longer than 200 nucleotides. They are considered a class of dynamic noncoding RNAs known to be involved in physiological and pathological conditions with regulatory and structural roles in numerous biological processes, including genomic imprinting, epigenetic regulation, cell proliferation, development, aging and apoptosis. They are emerging as potential key regulators of a variety of cardiovascular diseases. However, the roles of lncRNAs in the heart function remain largely unknown. The purpose of this review was to summarize the functions of lncRNAs in the heart and discuss the challenges and possible strategies of lncRNA research for cardiovascular disease.
心血管疾病是全球范围内主要的死亡和致残原因。最近,越来越多的证据表明,各种长链非编码 RNA(lncRNAs)在心血管疾病的发病机制中发挥着关键作用,包括心肌缺血再灌注(I/R)损伤。lncRNAs 是长度大于 200 个核苷酸的转录本。它们被认为是一类动态的非编码 RNA,已知参与多种生理和病理条件,在包括基因组印记、表观遗传调控、细胞增殖、发育、衰老和细胞凋亡等在内的众多生物学过程中具有调节和结构作用。它们正成为多种心血管疾病的潜在关键调控因子。然而,lncRNAs 在心脏功能中的作用在很大程度上仍然未知。本综述的目的是总结 lncRNAs 在心脏中的功能,并讨论 lncRNA 研究用于心血管疾病的挑战和可能策略。